Skip to content
Third-party HPLC + mass spec on every lot
Verified — all release criteria met
released

Certificate of analysis

Selank

Lot CP-SELANK-2605B · 30 mg

99.82 %

HPLC purity

Spec ≥ 99.0 %

89.3 %

Net peptide content

By amino acid analysis

< 0.61

Endotoxin (EU/mg)

Spec < 5.0 EU/mg

Provenance

Testing laboratory
Janoshik Analytical
Accreditation
ISO/IEC 17025:2017
Country of synthesis
United States
Manufactured
May 11, 2026
Release tested
May 20, 2026 (4 months ago)
Retest date
May 10, 2028
CAS number
129954-34-3
Molecular formula
C33H57N11O9
Theoretical mass
751.88 Da
Observed mass (LC-MS)
751.99 Da (Δ 0.11 Da)

Assay results

Every line the release panel ran for this lot, with the method, the acceptance criterion and the measured value — not a pass mark alone.

Certificate of analysis — assay results
MethodParameterSpecificationResult
RP-HPLC (UV 214 nm)Purity (area %)≥ 99.0 %99.82 %Pass
LC-MS (ESI+)Identity — observed mass751.88 ± 1.0 Da751.99 DaPass
Amino acid analysisNet peptide content≥ 80.0 %89.3 %Pass
Karl FischerWater content≤ 8.0 %2.72 %Pass
Ion chromatographyResidual TFA≤ 1.0 %0.32 %Pass
LAL kinetic chromogenicBacterial endotoxin< 5.0 EU/mg< 0.61 EU/mgPass
USP <71> membrane filtrationSterilityNo growthNo growthPass
Visual / USP <790>AppearanceWhite to off-white cake, free of visible particulatesConformsPass

Sequence

H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH

Handling for this lot

Appearance
White lyophilised powder
Storage
-20 °C lyophilised
Reconstitution
Stable and straightforward. No special handling beyond standard cold-chain practice.

Other lots of Selank

Compare batch to batch. Consistency across lots is a stronger signal than any single certificate.

Research use only. This certificate describes material supplied strictly for laboratory research. It is not a drug, food, cosmetic or medical device, has not been evaluated by the FDA, and is not intended for human or veterinary administration of any kind.